Research.Patient.info
Carcinoma, Neuroendocrine research hub
2 indexed studies · 2 currently recruiting
- not yet recruitingPHASE2
Trial of FOLFIRI + Zimberelimab + Domvanalimab vs FOLFIRI With a Hybrid Synthetic Control Arm in Second Line Treatment of Neuroendocrine Carcinoma of Gastro-enteropancreatic or Unknown Origin (REWENEC 01)
This study looks at a new drug combination (FOLFIRI + Zimberelimab + Domvanalimab) for a rare, aggressive cancer called neuroendocrine carcinoma. It compares this new treatment to the standard FOLFIRI chemotherapy for people whose cancer has returned after initial treatment.
France - recruitingPHASE2
A Trial to Assess the Safety and Effectiveness of Lutetium-177 Octreotate Therapy in Neuroendocrine Tumours
This study looks at a special treatment called Lutetium-177 Octreotate for rare cancers called neuroendocrine tumours. It checks how safe and effective this treatment is, and how it affects patients' quality of life and survival.
Canada